Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Clinical Trials

Manufacture Small Molecules

Two Grand Challenges for Pharma

| Stephanie Sutton

A pair of medicines manufacturing initiatives are looking to improve continuous direct compression and clinical trial supply.

Manufacture Vaccines

COVID-19: Vaccine Development at Full Tilt

| Sheila Rocchio

Will the rapid development of COVID-19 vaccines lead to unsafe therapies?

Business & Regulation COVID-19

Cutting Through the Noise

| Stephanie Sutton

We curate the COVID-19 news and breakthroughs of 2020 to bring you a helicopter view of the global fight against COVID-19.

Discovery & Development Clinical Trials

Green Trials

| Stephanie Sutton

Implementing green practices in clinical trials.

Discovery & Development Vaccines

The Pfizer COVID-19 Vaccine

| Stephanie Sutton

Pfizer and BioNTech claim their two-dose COVID-19 mRNA vaccine (BNT162b2) is more than 90 percent effective.

Discovery & Development Clinical Trials

Pandemic Protection

| Stephanie Sutton

Fujifilm Toyama's influenza treatment passes COVID-19 trial.

Manufacture Vaccines

Don’t Exclude the Aged

| Stephanie Sutton

Most clinical trials against COVID-19 exclude the very patients most at risk from the disease.

Manufacture Bioprocessing - Single Use Systems

The Power List 2021: Nominate Now

| Stephanie Sutton

Nominations are now open for The Medicine Maker 2021 Power List.

Discovery & Development Clinical Trials

A Matter of Trust

| Maryam Mahdi

Can we trust the integrity of clinical trials?

Discovery & Development Clinical Trials

A Rare Opportunity for Change

| Maryam Mahdi

AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register